0000000000413480

AUTHOR

Tagliabue Giovanna

showing 2 related works from this author

Molecular Subtypes, Metastatic Pattern and Patient Age in Breast Cancer: An Analysis of Italian Network of Cancer Registries (AIRTUM) Data

2021

Breast cancer stage at diagnosis, patient age and molecular tumor subtype influence disease progression. The aim of this study was to analyze the relationships between these factors and survival in breast cancer patients among the Italian population using data from the AIRTUM national database. We enrolled women with primary breast cancer from 17 population-based cancer registries. Patients were subdivided into older (>69 years), middle (50–69 years) and younger age groups (<50 years) and their primary tumors categorized into four molecular subtypes based on hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status. There were 8831 patients diagnosed betwe…

hormone receptor (HR)Rhormone receptor (HR); human epidermal growth factor receptor 2 (HER2); breast cancer; metastasis; age; population-based; cancer registryGeneral MedicineSettore MED/42 - Igiene Generale E ApplicataArticleAge Breast cancer Cancer registry Hormone receptor (HR) Human epidermal growth factor receptor 2 (HER2) Metastasis Population‐basedpopulation-basedbreast cancerhuman epidermal growth factor receptor 2 (HER2)agecancer registrymetastasisMedicineJournal of Clinical Medicine; Volume 10; Issue 24; Pages: 5873
researchProduct

Treatment challenges in and outside a network setting: Soft tissue sarcomas

2019

Patients with soft tissue sarcoma (STS) experienced better outcomes when treated according to existing clinical practice guidelines either at reference institution or dedicated treatment networks. Despite increasing evidence supporting referral to sarcoma specialised units, up to half of patients are not managed according to guidelines, particularly those in the early stage of their disease requiring surgery. Also, criteria to certify expertise of institutions, such as the treatment volume, are debated and health authorities have only recently started identification of these centres and creation of treatment networks in Europe as well as in several countries. This process have important imp…

medicine.medical_specialtyGuidelines; Network; Referral centre; Sarcoma; Treatment; Surgery; OncologyReferralReferral centrePopulationMEDLINESocio-culturaleNetworkDiseaseCancer Care FacilitiesGuidelinesGuideline03 medical and health sciencesRare Diseases0302 clinical medicineRare DiseaseHealth careGuidelines; Network; Referral centre; Sarcoma; TreatmentmedicineHumans030212 general & internal medicineRegistrieseducationReferral and Consultationeducation.field_of_studybusiness.industryCancer Care FacilitieSoft tissue sarcomaCancer Care FacilitiesSarcomaGeneral Medicinemedicine.diseaseSurgeryTreatmentEuropeClinical researchOncology030220 oncology & carcinogenesisPractice Guidelines as TopicSurgeryMedical emergencybusinessDelivery of Health CareHuman
researchProduct